Assess the effectiveness and safety of progesterone receptor modulators in managing endometriosis.

OA: green CC0
⚙ AI-generated summary by qwen3.7-flash, 2026-10-07 ⓘ

This paper assesses the effectiveness and safety of progesterone receptor modulators, including dienogest, gestrinone, and mifepristone, for managing endometriosis symptoms while highlighting their distinct safety profiles.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-10-07 · read from full text ⓘ

This paper evaluates the clinical effectiveness and safety profiles of various progesterone receptor modulators, including dienogest, gestrinone, and mifepristone, for the management of endometriosis. The authors analyze how these distinct pharmacological agents provide effective symptom relief while highlighting the necessity for careful consideration of their specific safety characteristics in clinical practice. By comparing the different modulators, the study aims to guide appropriate selection based on individual patient needs and risk factors. This paper is centrally about endometriosis — specifically evaluating the therapeutic role of progesterone receptor modulators in managing the condition.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Progesterone receptor modulators such as dienogest, gestrinone, and mifepristone offer effective symptom management for endometriosis, each with distinct safety profiles requiring careful consideration in clinical practice.
Full text 562 characters · extracted from oa-doi-fallback · click to expand
Published October 2, 2026 | Version v1 Other Open Assess the effectiveness and safety of progesterone receptor modulators in managing endometriosis. Description Progesterone receptor modulators such as dienogest, gestrinone, and mifepristone offer effective symptom management for endometriosis, each with distinct safety profiles requiring careful consideration in clinical practice. Files 4e940ce6-11fd-45c3-ad1d-407df9b29edc.pdf Files (18.5 kB) | Name | Size | Download all | |---|---|---| | md5:7f7e7b3c867bcf54c317b4d086609f58 | 18.5 kB | Preview Download |

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

openalex
last seen: 2026-10-07T06:01:52.021920+00:00
License: CC0 · commercial use OK